Pharming Group (PHAR) analyst forecast and price target
Analyst forecast
Consensus of 7 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $38.00 from $37.00 | Aug 3, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $37.00 | Apr 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Mar 24, 2026 |
| Oppenheimer | Maintained | Outperform | $41.00 from $42.00 | Mar 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Mar 21, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Mar 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Mar 14, 2025 |
| Oppenheimer | Maintained | Outperform | $39.00 from $30.00 | Mar 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Dec 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Dec 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Dec 11, 2024 |
| Jefferies | Initiated Coverage | Buy | $14.00 | Dec 9, 2024 |
| Oppenheimer | Maintained | Outperform | $30.00 from $31.00 | Oct 28, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Oct 24, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Oct 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Oct 10, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Sep 26, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Aug 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | May 31, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $37.00 | Mar 14, 2024 |
Frequently asked questions
Is PHAR a buy, sell, or hold?
Analysts covering Pharming Group currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PHAR?
On Aug 3, 2026, Canaccord Genuity maintained Pharming Group at Buy with a price target of $38.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.